News

Green Griffith Partners Are 2018 Life Sciences Stars

Green Griffith is pleased to announce that founding partners Bob Green, Chris Griffith and Caryn Borg-Breen have been na…
Read More >

Caryn Borg-Breen: Putting the Intellect into IP Law Practice

Green Griffith is pleased to announce that founding partner, Caryn Borg-Breen, has been featured in Leading Lawyers 2018…
Read More >

Bob Green Named One of The Best Lawyers in America 2019

Green Griffith is pleased to announce that founding partner Bob Green has been selected by his peers for inclusion in Th…
Read More >

USPTO Changes Claim Construction Standard for Patent Trial and Appeal Board (PTAB) Proceedings

The USPTO, in a final rule (a copy of which may be accessed here), has changed the claim construction standard to be use…
Read More >

Federal Circuit Denies Petition for Rehearing En Banc of Vanda Pharmaceuticals Decision Concerning the Patentability of Method of Treatment Claims Under Section 101

The Federal Circuit’s April 13, 2018, Vanda decision (a copy may be found here) affirmed the district courtȁ…
Read More >

Federal Circuit Clarifies the Statutory Time Bar Applicable to Petitions for Inter Partes Review

Section 315(b) states, “An inter partes review may not be instituted if the petition requesting the proceeding is…
Read More >

PTAB Panel Asserts It Need Not Evaluate All Claims and Grounds When Deciding Whether to Institute an Inter Partes Review

A Patent Trial and Appeal Board (“PTAB”) panel denied a Patent Owner’s Request for Rehearing of its…
Read More >

The CREATES Act and its Provisions Affecting REMS Get Boost from Congressional Budget Office

The CBO released its analysis of the financial impact of the “Creating and Restoring Equal Access to Equivalent S…
Read More >

USPTO Issues Updates to PTAB Trial Practice Guide

USPTO has released an update to the PTAB Trial Practice Guide (“TPG”). A copy of this August 2018 update, …
Read More >

Federal Circuit Rejects USPTO’s Effort to Circumvent the “American Rule” Regarding Recovery of Attorneys’ Fees in § 145 Appeals

A divided Federal Circuit has determined that 35 U.S.C. § 145, which permits the USPTO to recover “all the e…
Read More >

Federal Circuit Broadens Test for Identifying the “Real Party in Interest” in Inter Partes Reviews

A determination of the “real party in interest” or “privy” of an IPR petitioner is significa…
Read More >

FDA Seeks Comments on Exclusivity and Label Carve-Outs for Biologics

As part of its “Biosimilars Action Plan” released on July 18, 2018 (discussed here), FDA will conduct a he…
Read More >